Open nowRolling / open intakeAward: Varies
RLT-Connect
Radioligand therapy accessRadiotheranosticsCancer treatment access+1 more
Who can apply: Healthcare professionals working in centers that already use 177Lu and have experience treating patients with 177Lu radiopharmaceuticals. Patients cannot register themselves. Centers must register on the platform, be approved, and sign the RLT-Connect ethical charter and related agreements. Requests are evaluated against pre-defined eligibility criteria and an ad hoc committee's review.
Deadline: No fixed deadline; requests are processed after center approval and dose requests are submitted through the platform. Suppliers are asked to provide doses at least 20 days in advance once a case is accepted.